151 related articles for article (PubMed ID: 8787211)
1. Neuropeptide Y (NPY) and its mRNA in discrete brain areas after subchronic administration of neuroleptics.
Herman ZS
Acta Neurobiol Exp (Wars); 1996; 56(1):55-61. PubMed ID: 8787211
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Obuchowicz E
Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
[TBL] [Abstract][Full Text] [Related]
4. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
Obuchowicz E; Turchan J
Neuropeptides; 1998 Oct; 32(5):473-80. PubMed ID: 9845010
[TBL] [Abstract][Full Text] [Related]
5. Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jun; 9(4):329-35. PubMed ID: 10422894
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.
Huang XF; Deng C; Zavitsanou K
Neuropeptides; 2006 Jun; 40(3):213-9. PubMed ID: 16516965
[TBL] [Abstract][Full Text] [Related]
7. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Obuchowicz E; Herman ZS
Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y (NPY) mRNA in rat brain tissue: effects of decapitation and high-energy microwave irradiation on post mortem stability.
Thorsell A; Gruber SH; Mathé AA; Heilig M
Neuropeptides; 2001; 35(3-4):168-73. PubMed ID: 11884207
[TBL] [Abstract][Full Text] [Related]
9. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
Ault DT; Radeff JM; Werling LL
J Pharmacol Exp Ther; 1998 Feb; 284(2):553-60. PubMed ID: 9454797
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
Waters SM; Konkoy CS; Davis TP
J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
[TBL] [Abstract][Full Text] [Related]
11. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence.
Zhang LP; Wang L
Acta Pharmacol Sin; 2005 Nov; 26(11):1290-6. PubMed ID: 16225749
[TBL] [Abstract][Full Text] [Related]
12. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
Mijnster MJ; Schotte A; Docter GJ; Voorn P
Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
[TBL] [Abstract][Full Text] [Related]
13. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
[TBL] [Abstract][Full Text] [Related]
14. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
See RE; Lynch AM; Sorg BA
Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
[TBL] [Abstract][Full Text] [Related]
15. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
Hsieh YS; Yang SF; Chu SC; Kuo DY
J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
[TBL] [Abstract][Full Text] [Related]
16. Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats.
de Lange RP; Wiegant VM; Stam R
Brain Res; 2008 May; 1212():35-47. PubMed ID: 18440496
[TBL] [Abstract][Full Text] [Related]
17. Localization of neuropeptide Y mRNA and peptide in the chicken hypothalamus and their alterations after food deprivation, dehydration, and castration.
Kameda Y; Miura M; Nishimaki T
J Comp Neurol; 2001 Jul; 436(3):376-88. PubMed ID: 11438937
[TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression.
Jiménez-Vasquez PA; Diaz-Cabiale Z; Caberlotto L; Bellido I; Overstreet D; Fuxe K; Mathé AA
Eur Neuropsychopharmacol; 2007 Mar; 17(4):298-308. PubMed ID: 16904299
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
20. Young adult-specific hyperphagia in diabetic Goto-kakizaki rats is associated with leptin resistance and elevation of neuropeptide Y mRNA in the arcuate nucleus.
Maekawa F; Fujiwara K; Kohno D; Kuramochi M; Kurita H; Yada T
J Neuroendocrinol; 2006 Oct; 18(10):748-56. PubMed ID: 16965293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
